Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP156631.RArhYenS9028oZiBVlcEQpf5YiYTY3ps0AgHJJMoEExbc130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156631.RArhYenS9028oZiBVlcEQpf5YiYTY3ps0AgHJJMoEExbc130_provenance.
• NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595621.RAU38GOZD_5Ntdnuq-zz-CDLE9MLLOeKznBP2b85cxZKk130_provenance.
• NP571095.RAsH345tpfo2UY2KfB9EaJKT6SxzO60YZOswHcUpFlJ7g130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571095.RAsH345tpfo2UY2KfB9EaJKT6SxzO60YZOswHcUpFlJ7g130_provenance.
• NP737473.RAB3kXfklMaL_ZZ2oeQoShTJTLAUbjP4DUBrBd2hmX3NA130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737473.RAB3kXfklMaL_ZZ2oeQoShTJTLAUbjP4DUBrBd2hmX3NA130_provenance.
• NP787204.RAtWTixj-tyJdJ6Eg_he_Z-p5UUyiNzPfVsDVTZerSa-k130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787204.RAtWTixj-tyJdJ6Eg_he_Z-p5UUyiNzPfVsDVTZerSa-k130_provenance.
• NP524568.RA-QDNN711KCwprxDwxDUed4yIzctcns0V-Q6P9N4z1EU130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524568.RA-QDNN711KCwprxDwxDUed4yIzctcns0V-Q6P9N4z1EU130_provenance.
• NP600411.RAN3EQDNr1xSxBlfjVKLSWCHhi7cG7RSTR7h7fW-35Twc130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600411.RAN3EQDNr1xSxBlfjVKLSWCHhi7cG7RSTR7h7fW-35Twc130_provenance.
• assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP793625.RAYy6uaGX-g01GarKUnrtjgCV9CUnprmx22K175Ein8jw130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793625.RAYy6uaGX-g01GarKUnrtjgCV9CUnprmx22K175Ein8jw130_provenance.
• NP793634.RAxjdUNEDDYio2DUzngmMuHsmXaNxp2E4K5ePHV06uq5M130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793634.RAxjdUNEDDYio2DUzngmMuHsmXaNxp2E4K5ePHV06uq5M130_provenance.
• NP290292.RAynsIS7jWuItEJTLAjLwZBOtNwRvZAcz06-Zr-Q9JGDc130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290292.RAynsIS7jWuItEJTLAjLwZBOtNwRvZAcz06-Zr-Q9JGDc130_provenance.
• NP290288.RARP0uSBpX3mVHp6Ys30u2H9b6juRvIRZ8PirLfKYCA-Q130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290288.RARP0uSBpX3mVHp6Ys30u2H9b6juRvIRZ8PirLfKYCA-Q130_provenance.
• NP290289.RAX6cLSyWZU1Jlvv-nTP_vLSYkGpbZ_NPnUpjN3xtAFXc130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290289.RAX6cLSyWZU1Jlvv-nTP_vLSYkGpbZ_NPnUpjN3xtAFXc130_provenance.
• NP290290.RAZtT9oqFA1hE3A9Yc3BYC0z4NYunlT6YmYAdbMKDFYn0130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290290.RAZtT9oqFA1hE3A9Yc3BYC0z4NYunlT6YmYAdbMKDFYn0130_provenance.
• NP793622.RAO8YDWzsO0-HY1Sm3kzGrZ12XFcXY-lOhx9IU6UprR5U130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793622.RAO8YDWzsO0-HY1Sm3kzGrZ12XFcXY-lOhx9IU6UprR5U130_provenance.
• NP290291.RAHwPQQQ5r6g7WWcWs5lfNF6E1oPTljYuiaH2nPOTeZ_Q130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290291.RAHwPQQQ5r6g7WWcWs5lfNF6E1oPTljYuiaH2nPOTeZ_Q130_provenance.
• NP737580.RAkeIex7u_GqoTQm3aZU-LGKKY3NxHrnaDF3VQFG5u2Ig130_assertion description "[If these mitogenic effects of EPO are also operative in patients with RCC, endogenous EPO or its administration for the treatment of anemia could potentially hasten proliferation of renocellular malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737580.RAkeIex7u_GqoTQm3aZU-LGKKY3NxHrnaDF3VQFG5u2Ig130_provenance.